help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Biophys J. BioFAST on November 9, 2007.
doi:10.1529/biophysj.107.108175
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
biophysj.107.108175v1
94/5/1782    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valéry, C.
Right arrow Articles by Paternostre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valéry, C.
Right arrow Articles by Paternostre, M.
Biophysical Journal 94:1782-1795 (2008)
© 2008 The Biophysical Society

Molecular Origin of the Self-Assembly of Lanreotide into Nanotubes: A Mutational Approach

Céline Valéry *, Emilie Pouget {dagger}, Anjali Pandit {ddagger}, Jean-Marc Verbavatz {ddagger}, Luc Bordes {ddagger}, Isabelle Boisdé {ddagger}, Roland Cherif-Cheikh *, Franck Artzner {dagger} and Maité Paternostre {ddagger}

* Ipsen Pharma, 08980 Sant Feliu de Llobregat, Barcelona, Spain; {dagger} Unité mixte de Recherche du Centre National pour la Recherche Scientifique 6626, Université Rennes 1, F-35042 Rennes, France; and {ddagger} Institut de Bio Technologies de Saclay, Commisariat à l'Energie Atomique et Centre National pour la Recherche Scientifique, F-91191 Gif-sur-Yvette, France

Correspondence: Address reprint requests to Maité Paternostre, Institut de BioTechnologies de Saclay, CEA-Saclay, URA 2096, 91191 Gif-sur-Yvette, France. Tel.: 33-1-69-08-67-49; Fax: 33-1-69-08-43-89; E-mail: maite.paternostre{at}cea.fr.

Lanreotide, a synthetic, therapeutic octapeptide analog of somatostatin, self-assembles in water into perfectly hollow and monodisperse (24-nm wide) nanotubes. Lanreotide is a cyclic octapeptide that contains three aromatic residues. The molecular packing of the peptide in the walls of a nanotube has recently been characterized, indicating four hierarchical levels of organization. This is a fascinating example of spontaneous self-organization, very similar to the formation of the gas vesicle walls of Halobacterium halobium. However, this unique peptide self-assembly raises important questions about its molecular origin. We adopted a directed mutation approach to determine the molecular parameters driving the formation of such a remarkable peptide architecture. We have modified the conformation by opening the cycle and by changing the conformation of a Lys residue, and we have also mutated the aromatic side chains of the peptide. We show that three parameters are essential for the formation of lanreotide nanotubes: i), the specificity of two of the three aromatic side chains, ii), the spatial arrangement of the hydrophilic and hydrophobic residues, and iii), the aromatic side chain in the β-turn of the molecule. When these molecular characteristics are modified, either the peptides lose their self-assembling capability or they form less-ordered architectures, such as amyloid fibers and curved lamellae. Thus we have determined key elements of the molecular origins of lanreotide nanotube formation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Biophysical Society.